Terran Biosciences announces licensing deal with Sanofi
Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics
Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics
These new chemical entities are covered by composition of matter patent applications. Financial terms of the deal were not disclosed
Subscribe To Our Newsletter & Stay Updated